Chairman
Marksans Pharma Limited
Equibles does not estimate personal net worth.
Mark Saldana is recorded as Chairman at Marksans Pharma Limited. Mark Saldana has spoken on 4 earnings calls across 1 company, most recently for Marksans Pharma Limited on November 5, 2026. Marksans Pharma Limited is classified in the Drug Manufacturers - General industry within the Healthcare sector.
“We appreciate your continued interest in the company and your support. I'm pleased to share that we have delivered our strongest quarterly performance. Q2 was a record quarter for us with a revenue from operation reaching 940 crores, representing an year-on-year growth of 30.5%.”
“Good afternoon, everyone, and thank you for joining us for our Q1FI27 earning conference call. We sincerely appreciate your interest and continued support for the company.”
“Welcome, everyone, and thank you for joining us for our Q4 and FY26 earning conference call. We sincerely appreciate your interest and continued support for the company.”
“Welcome, everyone, and thank you for joining us for our Q3 and nine months FI26 earning conference call. We sincerely appreciate your interest and continued support for the company.”
Marksans Pharma Limited
Chairman
Transcript header (unverified)
Marksans Pharma Limited
Drug Manufacturers - General · Healthcare
Chairman
Earnings Call for the Quarter Ended September 30, 2026
Marksans Pharma Limited
Earnings Call
Marksans Pharma Limited
Marksans Pharma Limited Q4 FY26 Earnings Conference Call
Marksans Pharma Limited
“Marksans Pharma Limited Q3 FY26 Earnings Conference Call”
Marksans Pharma Limited
